ID

21157

Description

A Retrospective Case-Control Study to Estimate the Sensitivity and Specificity of a Pharmacogenetic Marker (HLA-B*5701) in Subjects With and Without Hypersensitivity to Abacavir Assessment: End of Study NCT00373945 / VIIV-ABC107442 Annotated Design For Trial:abc442_lgm Protocol:ABC107442 Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus I, Phase: 4, Clinical Study ID: ABC107442, Sponsor: ViiV

Mots-clés

  1. 4/12/17 4/12/17 -
Téléchargé le

April 12, 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

HLA-B*5701 And Hypersensitivity To Abacavir End of Study NCT00373945

HLA-B*5701 And Hypersensitivity To Abacavir End of Study NCT00373945

Date of Visit/Assessment
Description

Date of Visit/Assessment

Alias
UMLS CUI-1
C1320303
Date of Visit/Assessment
Description

Date of Visit/Assessment

Type de données

date

Alias
UMLS CUI [1]
C1320303
Study Conclusion
Description

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Date of subject completion or date of subject withdrawal
Description

Date of subject completion or date of subject withdrawal

Type de données

date

Alias
UMLS CUI [1,1]
C2983670
UMLS CUI [1,2]
C0422727
Was the subject withdrawn from the study?
Description

Was the subject withdrawn from the study?

Type de données

text

Alias
UMLS CUI [1]
C0422727
Primary reason for withdrawal
Description

Please specify if "Was the subject withdrawn from the study?"=Yes

Type de données

integer

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
Did the subject experience any non-serious adverse events during the study?
Description

Did the subject experience any non-serious adverse events during the study?

Type de données

text

Alias
UMLS CUI [1]
C1518404
Did the subject experience any serious adverse events during the study?
Description

Did the subject experience any serious adverse events during the study?

Type de données

text

Alias
UMLS CUI [1]
C1519255
Were any concomitant medications taken by the subject during the study?
Description

Were any concomitant medications taken by the subject during the study?

Type de données

text

Alias
UMLS CUI [1]
C2347852
Case book ready for signature
Description

CRA should check the box when data cleaning is complete

Type de données

text

Alias
UMLS CUI [1]
C1519316
Q1
Description

Q1

Type de données

text

Q2
Description

Q2

Type de données

text

Pregnancy Information
Description

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did the subject become pregnant during the study?
Description

If Yes, complete the paper Pregnancy Notification form

Type de données

text

Alias
UMLS CUI [1]
C0032961
PGx-Pharmacogenetic Research Withdrawal of Consent
Description

PGx-Pharmacogenetic Research Withdrawal of Consent

Alias
UMLS CUI-1
C1707492
UMLS CUI-2
C0021430
Has subject withdrawn consent for PGx-Pharmacogenetic Research?
Description

Has subject withdrawn consent for PGx-Pharmacogenetic Research?

Type de données

text

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0021430
Has a request been made for sample destruction?
Description

Has a request been made for sample destruction?

Type de données

text

Alias
UMLS CUI [1,1]
C1948029
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C1272683
Reason for sample destruction
Description

Please specify if "Has a request been made for sample destruction?"=Yes

Type de données

integer

Alias
UMLS CUI [1,1]
C1948029
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C0392360
Sample type
Description

Sample type

Type de données

text

Alias
UMLS CUI [1]
C2347029
Genetics Type
Description

Genetics Type

Type de données

text

Alias
UMLS CUI [1]
C0017399
Investigator Signature
Description

Investigator Signature

Alias
UMLS CUI-1
C2346576
Is this casebook ready to sign?
Description

Is this casebook ready to sign?

Type de données

text

Alias
UMLS CUI [1]
C2346576

Similar models

HLA-B*5701 And Hypersensitivity To Abacavir End of Study NCT00373945

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Date of Visit/Assessment
C1320303 (UMLS CUI-1)
Date of Visit/Assessment
Item
Date of Visit/Assessment
date
C1320303 (UMLS CUI [1])
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Date of subject completion or date of subject withdrawal
Item
Date of subject completion or date of subject withdrawal
date
C2983670 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
Item
Was the subject withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Code List
Was the subject withdrawn from the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Primary reason for withdrawal
integer
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
Primary reason for withdrawal
CL Item
Adverse Event, Record details on the Non-Serious Adverse Event or Serious Adverse Events forms as appropriate (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (5)
CL Item
Other, specify (6)
Item
Did the subject experience any non-serious adverse events during the study?
text
C1518404 (UMLS CUI [1])
Code List
Did the subject experience any non-serious adverse events during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Did the subject experience any serious adverse events during the study?
text
C1519255 (UMLS CUI [1])
Code List
Did the subject experience any serious adverse events during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Were any concomitant medications taken by the subject during the study?
text
C2347852 (UMLS CUI [1])
Code List
Were any concomitant medications taken by the subject during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Case book ready for signature
text
C1519316 (UMLS CUI [1])
Code List
Case book ready for signature
CL Item
Yes (Y)
Item
Q1
text
CL Item
No (N)
CL Item
Yes (Y)
Q2
Item
Q2
text
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Item
Did the subject become pregnant during the study?
text
C0032961 (UMLS CUI [1])
Code List
Did the subject become pregnant during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item Group
PGx-Pharmacogenetic Research Withdrawal of Consent
C1707492 (UMLS CUI-1)
C0021430 (UMLS CUI-2)
Item
Has subject withdrawn consent for PGx-Pharmacogenetic Research?
text
C1707492 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Code List
Has subject withdrawn consent for PGx-Pharmacogenetic Research?
CL Item
No (N)
CL Item
Yes (Y)
Item
Has a request been made for sample destruction?
text
C1948029 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
Code List
Has a request been made for sample destruction?
CL Item
No (N)
CL Item
Yes (Y)
Item
Reason for sample destruction
integer
C1948029 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Code List
Reason for sample destruction
CL Item
Subject requested (1)
CL Item
Screen failure (2)
CL Item
Other, specify (3)
Sample type
Item
Sample type
text
C2347029 (UMLS CUI [1])
Genetics Type
Item
Genetics Type
text
C0017399 (UMLS CUI [1])
Item Group
Investigator Signature
C2346576 (UMLS CUI-1)
Item
Is this casebook ready to sign?
text
C2346576 (UMLS CUI [1])
Code List
Is this casebook ready to sign?
CL Item
Yes (Y)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial